Essential role of OX40L on B cells in persistent alloantibody production following repeated alloimmunizations

被引:16
作者
Kato, H
Kojima, H
Ishii, N
Hase, H
Imai, Y
Fujibayashi, T
Sugamura, K
Kobata, T
机构
[1] Dokkyo Univ, Sch Med, Inst Med Sci, Div Immunol, Mibu, Tochigi 3210293, Japan
[2] Dokkyo Univ, Sch Med, Dept Oral Surg, Mibu, Tochigi 3210293, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Microbiol & Immunol, Sendai, Miyagi 980, Japan
关键词
transfusion; OX40; ligand; alloantibody; lymphocyte; memory;
D O I
10.1023/B:JOCI.0000025445.21894.e5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
OX40/OX40 ligand (OX40L) interactions are implicated in costimulation for both CD4(+) T and B cells in a bidirectional manner. To determine the role of OX40/OX40L interactions in recipient antidonor responses after multiple allogeneic transfusions, we examined alloreactive cytotoxic T lymphocyte (allo-CTL) activity and alloantibody production in repeatedly alloimmunized OX40L-deficient mice. After the fifth alloimmunization, whereas OX40L-deficient mice showed allo-CTL activity with levels comparable to those of wild-type mice, alloantibody production in OX40L-deficient mice was significantly reduced, accompanied by fewer memory B and CD4C T cells with reduced function. Furthermore, nu/nu mice that received OX40L-deficient T cells still exhibited impaired alloantibody production with fewer memory CD4C T and B cells. In contrast, RAG-2-deficient mice that received both wild-type T cells and OX40L-deficient B cells produced scant alloantibodies with fewer memory B cells, but sufficient memory CD4C T cells. Thus, OX40L on B cells, rather than on T cells, is apparently required for adequate and persistent production of alloantibodies after repeated alloimmunizations.
引用
收藏
页码:237 / 248
页数:12
相关论文
共 62 条
[1]   Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis [J].
Akiba, H ;
Miyahira, Y ;
Atsuta, M ;
Takeda, K ;
Nohara, C ;
Futagawa, T ;
Matsuda, H ;
Aoki, T ;
Yagita, H ;
Okumura, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (02) :375-380
[2]  
Akiba H, 1999, J IMMUNOL, V162, P7058
[3]   OX40 is differentially expressed on activated rat and mouse T cells and is the sole receptor for the OX40 ligand [J].
AlShamkhani, A ;
Birkeland, ML ;
Puklavec, M ;
Brown, MH ;
James, W ;
Barclay, AN .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) :1695-1699
[4]   Affinity and kinetics of the interaction between soluble trimeric OX40 ligand, a member of the tumor necrosis factor superfamily, and its receptor OX40 on activated T cells [J].
AlShamkhani, A ;
Mallett, S ;
Brown, MH ;
James, W ;
Barclay, AN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (08) :5275-5282
[5]  
ANDREU G, 1988, BLOOD, V72, P964
[6]   Signaling through OX40 (CD134) breaks peripheral T-cell tolerance [J].
Bansal-Pakala, P ;
Jember, AGH ;
Croft, M .
NATURE MEDICINE, 2001, 7 (08) :907-912
[7]   MOLECULAR CHARACTERIZATION OF MURINE AND HUMAN OX40/OX40 LIGAND SYSTEMS - IDENTIFICATION OF A HUMAN OX40 LIGAND AS THE HTLV-1-REGULATED PROTEIN GP34 [J].
BAUM, PR ;
GAYLE, RB ;
RAMSDELL, F ;
SRINIVASAN, S ;
SORENSEN, RA ;
WATSON, ML ;
SELDIN, MF ;
BAKER, E ;
SUTHERLAND, GR ;
CLIFFORD, KN ;
ALDERSON, MR ;
GOODWIN, RG ;
FANSLOW, WC .
EMBO JOURNAL, 1994, 13 (17) :3992-4001
[8]   Acute and delayed hemolytic transfusion reactions secondary to HLA alloimmunization [J].
Benson, K ;
Agosti, SJ ;
Latoni-Benedetti, GE ;
Leparc, GF .
TRANSFUSION, 2003, 43 (06) :753-757
[9]  
BERKE G, 1993, CYTOTOXIC CELLS RECO, P113
[10]  
BLAJCHMAN MA, 1992, BLOOD, V79, P1371